
Grant funding worth nearly €800,000 to develop antiviral awarded
France’s National Research Agency (ANR) and Defense Innovation Agency (AID) will finance the BUNYANTIVIR project to introduce a novel therapeutic approach for Bunyaviricetes’ class of human pathogenic viruses found in tropical and subtropical regions. The BUNYANTIVIR project has been selected under the call for proposals for the 2024 ASTRID Maturation… Read More

